Paola Usan Egea

Title: Paola Usan Egea: Innovator in Neurodegenerative Disease Treatment

Introduction

Paola Usan Egea is a prominent inventor based in Alpedrete-Madrid, Spain. She has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative and haematological diseases. With a total of 3 patents, her work has the potential to impact the lives of many patients suffering from these conditions.

Latest Patents

One of her latest patents involves the development of [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases. This invention relates to a new family of [1,10]-phenanthroline derivatives that are useful for treating or preventing neurodegenerative or haematological diseases. The patent also covers their use as a medicament and a pharmaceutical composition comprising these compounds.

Another significant patent focuses on the use of Collismycin and its derivatives as oxidative stress inhibitors. This invention highlights the potential of Collismycin in treating oxidative stress-induced diseases, particularly neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease.

Career Highlights

Throughout her career, Paola has worked with notable companies such as Noscira, S.A. and Neuropharma, S.A. Her experience in these organizations has contributed to her expertise in the field of neurodegenerative diseases and innovative treatments.

Collaborations

Paola has collaborated with several professionals in her field, including Ana Martinez Gil and Miguel Medina Padilla. These collaborations have further enriched her research and development efforts.

Conclusion

Paola Usan Egea is a dedicated inventor whose work in the treatment of neurodegenerative diseases is paving the way for new therapeutic options. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.